It has been reported that intraventricular administration of the melan
ocortin 4 receptor (MCL4-R) agonist MT II and antagonist SHU9119 alter
food intake. We found that MT II and SHU9119 have extremely potent ef
fects on feeding when injected in the paraventricular nucleus (PVN), a
site where MC4-R gene expression is very high. Our finding provides d
irect evidence that MC4-R signaling is important is mediating food int
ake and that melanocortin neurons in the PVN exert a tonic inhibition
of feeding behavior. Chronic disruption of this inhibitory signal is a
possible explanation of the agouti-obesity syndrome. (C) 1998 Publish
ed by Elsevier Science B.V. All rights reserved.